News from Wednesday, December 24, 2025
Articles
Administration Releases Proposed Medicare International Drug Reference Pricing Models
(12/24, Kristi Martin, Rachel Sachs, Health Affairs Forefront) comments “...In this article, we describe key features of these proposed models, including implementation choices made by CMS; consider open questions remaining from the proposals’ release; and, analyze the implications for other important federal programs. Given the proposed models’ length (at a combined 560 pages), we focus only on a subset of important topics. Throughout, we situate these models within the broader context of the Trump Administration’s drug pricing reform strategy.” Full
Press Releases
Thousands More People with Advanced Bowel Cancer to Benefit as NICE Approves Bevacizumab Biosimilars
(12/24, NICE Press Release) “NICE has today published final draft guidance recommending bevacizumab with chemotherapy for people with metastatic colorectal cancer. This is the first time NICE has been able to recommend bevacizumab for colorectal cancer, following the availability of lower-cost biosimilar versions of the medicine.” Full
Journals
Charters in Patient-Engaged Research: A Scoping Review of Current Evidence
Jenny Martínez, et al.
December 22, 2025, Public Health Challenges
From Care to Cure: A Patient Engagement Framework for Rare Disease and Orphan Drug Research
Nahya Awada, et al.
December 23, 2025, Therapeutic Advances in Rare Disease